95 related articles for article (PubMed ID: 18546876)
1. [Treatment of childhood IgA nephropathy].
Yoshikawa N
Nihon Jinzo Gakkai Shi; 2008; 50(4):468-72. PubMed ID: 18546876
[No Abstract] [Full Text] [Related]
2. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[TBL] [Abstract][Full Text] [Related]
4. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.
Brown CB; Wilson D; Turner D; Cameron JS; Ogg CS; Chantler C; Gill D
Lancet; 1974 Nov; 2(7890):1166-72. PubMed ID: 4139590
[No Abstract] [Full Text] [Related]
5. Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function.
Savage JM; Postlethwaite RJ; Lendon M; Houston IB; Evans DI
Int J Pediatr Nephrol; 1982 Sep; 3(3):167-73. PubMed ID: 7141788
[No Abstract] [Full Text] [Related]
6. [Randomized controlled clinical trials for IgA nephropathies].
Yoshikawa T
Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():123-9. PubMed ID: 17899839
[No Abstract] [Full Text] [Related]
7. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
Yoshikawa N; Ito H
Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
[No Abstract] [Full Text] [Related]
8. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N; Honda M; Iijima K; Awazu M; Hattori S; Nakanishi K; Ito H;
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[TBL] [Abstract][Full Text] [Related]
9. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
Woo KT; Lee GS; Pall AA
Kidney Int; 2000 Jan; 57(1):348-9. PubMed ID: 10712116
[No Abstract] [Full Text] [Related]
10. Treating IgA Nephropathy - Who, When and How?
Feehally J
Nephron Clin Pract; 2003; 93(2):C47-8. PubMed ID: 12616029
[No Abstract] [Full Text] [Related]
11. Combined therapy in children and adolescents with IgA nephropathy.
Murakami K; Yoshioka K; Akano N; Takemura T; Okada M; Aya N; Hino S; Miyazato H; Yagi K; Maki S
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
[TBL] [Abstract][Full Text] [Related]
12. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
Brodsky SV; Rovin BH; Hebert LA
Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
[No Abstract] [Full Text] [Related]
13. [Comparative effectiveness of different therapeutic regimens in lupus nephritis in children and adolescents].
Kartasheva VI
Pediatriia; 1980 Apr; (4):45-50. PubMed ID: 7383790
[No Abstract] [Full Text] [Related]
14. [The effectiveness of cocktail therapy in the early treatment of children with MPGN type I, with special regard to remarkable histological improvement].
Tanizawa T; Miura K; Asada R; Matsukura H; Mase D; Inaba S; Tani M; Hara M; Higuchi A; Okada T
Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):401-12. PubMed ID: 3747251
[No Abstract] [Full Text] [Related]
15. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR
Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of IGA nephritis].
Risler T; Braun N
Dtsch Med Wochenschr; 2000 Aug; 125(34-35):996. PubMed ID: 11004910
[No Abstract] [Full Text] [Related]
17. [Tonsillectomy and steroid pulse therapy for IgA nephropathy].
Imai H; Miura N
Nihon Jinzo Gakkai Shi; 2008; 50(4):478-80. PubMed ID: 18546878
[No Abstract] [Full Text] [Related]
18. Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
Hotta O; Taguma Y; Kurosawa K; Sudo K; Suzuki K; Horigome I
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):967-73. PubMed ID: 8255008
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
Kawasaki Y; Hosoya M; Suzuki J; Onishi N; Takahashi A; Isome M; Nozawa R; Suzuki H
Am J Nephrol; 2004; 24(6):576-81. PubMed ID: 15550753
[TBL] [Abstract][Full Text] [Related]
20. Combined immunosuppression in high-risk patients with IgA nephropathy?
Floege J; Eitner F
J Am Soc Nephrol; 2010 Oct; 21(10):1604-6. PubMed ID: 20829408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
